Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-035988
Filing Date
2017-05-30
Accepted
2017-05-30 12:02:48
Documents
1
Period of Report
2017-05-25

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7723
  Complete submission text file 0001104659-17-035988.txt   9112
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791
Business Address
Sabba Stephen L (Reporting) CIK: 0001442372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 17876236